This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Williams HJ, Owen MJ, O’Donovan MC. Is COMT a susceptibility gene for schizophrenia? Schizophr Bull. 2007; 33(3): 635-461.WilliamsHJOwenMJO’DonovanMCIs COMT a susceptibility gene for schizophrenia?Schizophr Bull200733363546110.1093/schbul/sbm019252613917412710Search in Google Scholar
Varma GS, Karadağ OF, Erdal ME, Ay Öİ, Levent N, Tekkanat Ç, et al. Katekol-O-metiltransferaz geni Vall58 Met polimorfizminin şizofreni hastalarındaki bilişsel işlevlere Tiileri. Bull Clin Psychopharmacol. 2011; 21(1): 24-32.VarmaGSKaradağOFErdalMEAyÖİLeventNTekkanatÇet alKatekol-O-metiltransferaz geni Vall58 Met polimorfizminin şizofreni hastalarındaki bilişsel işlevlere TiileriBull Clin Psychopharmacol2011211243210.5350/KPB-BCP201121105Search in Google Scholar
Oswald LM, McCaul M, Choi L, Yang X, Wand GS. Catechol-O-methyltransferase polymorphism alters hypothalamic-pituitary-adrenal axis responses to naloxone: A preliminary report. Biol Psychiatry. 2004; 55(1): 102-105.OswaldLMMcCaulMChoiLYangXWandGSCatechol-O-methyltransferase polymorphism alters hypothalamic-pituitary-adrenal axis responses to naloxone: A preliminary reportBiol Psychiatry200455110210510.1016/j.biopsych.2003.07.00314706432Search in Google Scholar
Drabant EM, Hariri AR, Meyer-Lindenberg A, Munoz KE, Mattay VS, Kolachana BS, et al. Catechol O-methyltransferase val 15 8met genotype and neural mechanisms related to affective arousal and regulation. Arch Gen Psychiatry. 2006; 63(12): 1396-1406.DrabantEMHaririARMeyer-LindenbergAMunozKEMattayVSKolachanaBSet alCatechol O-methyltransferase val 15 8met genotype and neural mechanisms related to affective arousal and regulationArch Gen Psychiatry200663121396140610.1001/archpsyc.63.12.139617146014Search in Google Scholar
van Winkel R, Henquet C, Rosa A, Papiol S, Fañanás L, De Heret M, et al. Evidence that the COMT Val158 Met polymorphism moderates sensitivity to stress in psychosis: An experience sampling study. Am J Med Genet B Neuropsychiatr Genet. 2008; 147B(1): 10-17.van WinkelRHenquetCRosaAPapiolSFañanásLDe HeretMet alEvidence that the COMT Val158 Met polymorphism moderates sensitivity to stress in psychosis: An experience sampling studyAm J Med Genet B Neuropsychiatr Genet2008147B1101710.1002/ajmg.b.3055917525974Search in Google Scholar
Stein MB, Fallin MD, Schork NJ, Gelernter J. COMT polymorphisms and anxiety-related personality traits. Neuropsychopharmacology. 2005; 30(11): 2092-2102.SteinMBFallinMDSchorkNJGelernterJCOMT polymorphisms and anxiety-related personality traitsNeuropsychopharmacology200530112092210210.1038/sj.npp.130078715956988Search in Google Scholar
Lee D, Karschner EL, Milman G, Barnes AJ, Goodwin RS, Huestis MA. Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration? Drug Alcohol Depend. 2013; 130(1-3): 68-76.LeeDKarschnerELMilmanGBarnesAJGoodwinRSHuestisMACan oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?Drug Alcohol Depend20131301-3687610.1016/j.drugalcdep.2012.10.011361256023146820Search in Google Scholar
Crime UNOoDa. World Drug Report 2017: United Nations publication. Available from: https://www.unodc.org/wdr2017/index.htmlCrime UNOoDa. World Drug Report2017United Nations publication. Available fromhttps://www.unodc.org/wdr2017/index.htmlSearch in Google Scholar
Tomiyama K, Funada M. Cytotoxicity of synthetic cannabinoids found in “Spice” products: The role of can-nabinoid receptors and the caspase cascade in the NG 108-15 cell line. Toxicol Lett. 2011; 207(1): 12-17.TomiyamaKFunadaMCytotoxicity of synthetic cannabinoids found in “Spice” products: The role of can-nabinoid receptors and the caspase cascade in the NG 108-15 cell lineToxicol Lett20112071121710.1016/j.toxlet.2011.08.02121907772Search in Google Scholar
Su MK, Seely KA, Moran JH, Hoffman RS. Metabolism of classical cannabinoids and the synthetic cannabinoid JWH-018. Clin Pharmacol Ther. 2015; 97(6): 562-564.SuMKSeelyKAMoranJHHoffmanRSMetabolism of classical cannabinoids and the synthetic cannabinoid JWH-018Clin Pharmacol Ther201597656256410.1002/cpt.11425788107Search in Google Scholar
Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA. Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend. 2014; 144: 12-41.CastanetoMSGorelickDADesrosiersNAHartmanRLPirardSHuestisMASynthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implicationsDrug Alcohol Depend2014144124110.1016/j.drugalcdep.2014.08.005425305925220897Search in Google Scholar
Vandrey R, Dunn KE, Fry JA, Girling ER. A survey study to characterize use of Spice products (synthetic cannabinoids). Drug Alcohol Depend. 2012; 120(1-3): 238-241.VandreyRDunnKEFryJAGirlingERA survey study to characterize use of Spice products (synthetic cannabinoids)Drug Alcohol Depend20121201-323824110.1016/j.drugalcdep.2011.07.011321708621835562Search in Google Scholar
Ibrahim S, Al-Saffar F, Wannenburg T. A unique case of cardiac arrest following K2 abuse. Case Rep Cardiol. 2014;2014:120607.IbrahimSAl-SaffarFWannenburgTA unique case of cardiac arrest following K2 abuseCase Rep Cardiol2014201412060710.1155/2014/120607405541824963415Search in Google Scholar
Johnson LA, Johnson RL, Alfonzo C. Spice: A legal marijuana equivalent. Mil Med. 2011; 176(6): 718-720.JohnsonLAJohnsonRLAlfonzoCSpice: A legal marijuana equivalentMil Med2011176671872010.7205/MILMED-D-10-0035621702397Search in Google Scholar
Barratt MJ, Cakic V, Lenton S. Patterns of synthetic cannabinoid use in Australia. Drug Alcohol Rev. 2013; 32(2): 141-146.BarrattMJCakicVLentonSPatterns of synthetic cannabinoid use in AustraliaDrug Alcohol Rev201332214114610.1111/j.1465-3362.2012.00519.x23043552Search in Google Scholar
Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann Emerg Med. 2012; 60(4): 435-438.HoyteCOJacobJMonteAAAl-JumaanMBronsteinACHeardKJA characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010Ann Emerg Med201260443543810.1016/j.annemergmed.2012.03.00722575211Search in Google Scholar
Evren C, Ögel K. Alkol/madde bagimlilarinda dissosiyatif belirtiler ve çocukluk çagi travmasi, depresyon, anksiyete ve alkol/madde kullanimi ile iliskisi. (Dis-sociative symptoms among alcohol and substance dependents and its relationships with childhood trauma history, depression, anxiety, and alcohol/substance use.) Anatolian J Psychiatry. 2003; 4(1): 30.EvrenCÖgel K. Alkol/madde bagimlilarinda dissosiyatif belirtiler ve çocukluk çagi travmasi, depresyon, anksiyete ve alkol/madde kullanimi ile iliskisi. (Dis-sociative symptoms among alcohol and substance dependents and its relationships with childhood trauma history, depression, anxiety, and alcohol/substance use.)Anatolian J Psychiatry20034130Search in Google Scholar
Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J, et al. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci USA. 1997; 94(9): 4572-4575.KarayiorgouMAltemusMGalkeBLGoldmanDMurphyDLOttJet alGenotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorderProc Natl Acad Sci USA19979494572457510.1073/pnas.94.9.4572207649114031Search in Google Scholar
Klemetsdal B, Straume B, Giverhaug T, Aarbakke J. Low catechol-O-methyltransferase activity in a Saami population. Eur J Clin Pharmacol. 1994; 46(3): 231-235.KlemetsdalBStraumeBGiverhaugTAarbakkeJLow catechol-O-methyltransferase activity in a Saami populationEur J Clin Pharmacol199446323123510.1007/BF001925548070503Search in Google Scholar
Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA. 2001; 98(12): 6917-6922.EganMFGoldbergTEKolachanaBSCallicottJHMazzantiCMStraubREet alEffect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophreniaProc Natl Acad Sci USA200198126917692210.1073/pnas.1111345983445311381111Search in Google Scholar
Lachman HM, Papolos DF, Saito T, Yu Y-M, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics. 1996; 6(3): 243-250.LachmanHMPapolosDFSaitoTYuY-MSzumlanskiCLWeinshilboumRMHuman catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disordersPharmacogenetics19966324325010.1097/00008571-199606000-000078807664Search in Google Scholar
Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet. 2004; 75(5): 807-821.ChenJLipskaBKHalimNMaQDMatsumotoMMelhemSet alFunctional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brainAm J Hum Genet200475580782110.1086/425589118211015457404Search in Google Scholar
Tunbridge E, Weickert C, Kleinman J, Herman M, Chen J, Kolachana B, et al. Catechol-o-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan. Cereb Cortex. 2007; 17(5): 1206-1212.TunbridgeEWeickertCKleinmanJHermanMChenJKolachanaBet alCatechol-o-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespanCereb Cortex20071751206121210.1093/cercor/bhl03216835293Search in Google Scholar
Craddock N, O’Donovan MC, Owen MJ. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull. 2006; 32(1): 9-16.CraddockNO’DonovanMCOwenMJGenes for schizophrenia and bipolar disorder? Implications for psychiatric nosologySchizophr Bull200632191610.1093/schbul/sbj033263217516319375Search in Google Scholar
